Arrowhead Pharmaceuticals Inc (ARWR) — Cash Flow Quality Index
Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Quality Index of 1.25x as of March 2025. Operating cash flow of $460.05 Million exceeds net income of $367.86 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Arrowhead Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arrowhead Pharmaceuticals Inc Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Arrowhead Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Arrowhead Pharmaceuticals Inc generate cash.
Annual Cash Flow Quality Index for Arrowhead Pharmaceuticals Inc (1999–2025)
Year-by-year earnings quality comparison for Arrowhead Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.96x | $179.55 Million | $30.11 Million | ▲ +134.2% |
| 2019 | 2.55x | $173.03 Million | $67.97 Million | ▲ +100.0% |
| 2012 | -191754.63x | $-15.34 Million | $80.00 | ▼ -322877598.6% |
| 1999 | -0.06x | $-35.22K | $593.00K | — |